Upfront combination therapy with nintedanib and anti-inflammatory agents for progressive pulmonary fibrosis: a multicentre, single-arm phase 2 study (TOP-ILD)

Early combination therapy with tacrolimus, prednisolone and nintedanib was associated with improved pulmonary function and was well tolerated in previously untreated PPF patients. Our findings suggest the potential of this regimen as an initial treatment strategy, but further validation in larger randomised controlled trials is warranted.

Authors

Institutions

Publication Details

Journal
ERJ Open Research
Published
2025-09-18
DOI
https://doi.org/10.1183/23120541.00697-2025
Primary Topic
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Upfront combination therapy with nintedanib and anti-inflammatory agents for progressive pulmonary fibrosis: a multicentre, single-arm phase 2 study (TOP-ILD)

Yoshiaki Zaizen, Maki Asami‐Noyama, Kazuya Ichikado, Yuko Waseda et al.
ERJ Open Research
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
article

Upfront combination therapy with nintedanib and anti-inflammatory agents for progressive pulmonary fibrosis: a multicentre, single-arm phase 2 study (TOP-ILD)

Yoshiaki Zaizen, Maki Asami‐Noyama, Kazuya Ichikado, Yuko Waseda, Yasuhiro Kondoh, Osamu Nishiyama, Kazuya Tsubouchi, Hidenori Ichiyasu, Hirofumi Chiba, Noriho Sakamoto, Haruhiko Furusawa, Hiroshi Ishii, Isamu Okamoto, Reoto Takei, Tomoyuki Fujisawa, Kazunori Tobino, Masayuki Hirose, Takashi Ogura, Masaki Okamoto, Tomohisa Baba, Shinyu Izumi, Masanori Nakanishi
article en

Abstract

Early combination therapy with tacrolimus, prednisolone and nintedanib was associated with improved pulmonary function and was well tolerated in previously untreated PPF patients. Our findings suggest the potential of this regimen as an initial treatment strategy, but further validation in larger randomised controlled trials is warranted.

ERJ Open ResearchVol. 12(1)
Kurume University (JP), University of Fukui (JP), Kyushu University (JP), Sapporo Medical University (JP), Yamaguchi University (JP), Wakayama Medical University (JP), National Kyushu Medical Center (JP), Hamamatsu University School of Medicine (JP), Fukuoka University (JP), Tokyo Institute of Psychiatry (JP), National Center for Global Health and Medicine (JP), Saiseikai Kumamoto Hospital (JP), Kyushu University Hospital (JP), Aso Iizuka Hospital (JP), Kanagawa Cardiovascular and Respiratory Center (JP), Tosei General Hospital (JP), Nagasaki University (JP), Kindai University (JP), Kumamoto University (JP)
Openalex Percentile: Top 64%
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.